首页> 美国卫生研究院文献>Molecular Cellular Proteomics : MCP >Polymeric Microspheres as Protein Transduction Reagents
【2h】

Polymeric Microspheres as Protein Transduction Reagents

机译:高分子微球作为蛋白质转导试剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Discovering the function of an unknown protein, particularly one with neither structural nor functional correlates, is a daunting task. Interaction analyses determine binding partners, whereas DNA transfection, either transient or stable, leads to intracellular expression, though not necessarily at physiologically relevant levels. In theory, direct intracellular protein delivery (protein transduction) provides a conceptually simpler alternative, but in practice the approach is problematic. Domains such as HIV TAT protein are valuable, but their effectiveness is protein specific. Similarly, the delivery of intact proteins via endocytic pathways (e.g. using liposomes) is problematic for functional analysis because of the potential for protein degradation in the endosomes/lysosomes. Consequently, recent reports that microspheres can deliver bio-cargoes into cells via a non-endocytic, energy-independent pathway offer an exciting and promising alternative for in vitro delivery of functional protein. In order for such promise to be fully exploited, microspheres are required that (i) are stably linked to proteins, (ii) can deliver those proteins with good efficiency, (iii) release functional protein once inside the cells, and (iv) permit concomitant tracking. Herein, we report the application of microspheres to successfully address all of these criteria simultaneously, for the first time. After cellular uptake, protein release was autocatalyzed by the reducing cytoplasmic environment. Outside of cells, the covalent microsphere–protein linkage was stable for ≥90 h at 37 °C. Using conservative methods of estimation, 74.3% ± 5.6% of cells were shown to take up these microspheres after 24 h of incubation, with the whole process of delivery and intracellular protein release occurring within 36 h. Intended for in vitro functional protein research, this approach will enable study of the consequences of protein delivery at physiologically relevant levels, without recourse to nucleic acids, and offers a useful alternative to commercial protein transfection reagents such as Chariot™. We also provide clear immunostaining evidence to resolve residual controversy surrounding FACS-based assessment of microsphere uptake.
机译:发现一种未知蛋白质的功能,尤其是既没有结构关联也没有功能关联的蛋白质,是一项艰巨的任务。相互作用分析确定结合伴侣,而瞬时或稳定的DNA转染可导致细胞内表达,尽管不一定在生理上相关的水平。从理论上讲,直接向细胞内传递蛋白质(蛋白质转导)在概念上提供了更简单的选择,但在实践中该方法存在问题。诸如HIV TAT蛋白之类的结构域很有价值,但其有效性是蛋白特异的。类似地,由于内体/溶酶体中蛋白质降解的潜力,经由内吞途径(例如使用脂质体)递送完整蛋白对于功能分析是有问题的。因此,最近的报道表明,微球可以通过非内吞,不依赖能量的途径将生物货物输送到细胞中,为体外功能蛋白的输送提供了令人兴奋且有希望的选择。为了充分利用这种希望,要求微球体(i)稳定地与蛋白质连接,(ii)可以高效递送这些蛋白质,(iii)一旦进入细胞内就释放功能性蛋白质,并且(iv)允许伴随跟踪。本文中,我们首次报道了微球在同时成功解决所有这些标准方面的应用。细胞摄取后,减少的胞质环境自动催化蛋白质释放。在细胞外,共价微球与蛋白质的连接在37°C下稳定≥90 h。使用保守的估计方法,在孵育24小时后,有74.3%±5.6%的细胞被摄入了这些微球,整个递送过程和细胞内蛋白质释放发生在36小时之内。旨在进行体外功能蛋白质研究,这种方法将能够在生理相关水平上研究蛋白质递送的后果,而无需求助于核酸,并为商业蛋白质转染试剂(如Chariot™)提供了有用的替代方法。我们还提供明确的免疫染色证据,以解决围绕基于FACS的微球摄取评估所引起的残留争议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号